The company is outgrowing its own explanations: management keeps telling investors the reported numbers are not the busi
The model's full reasoning — Q4 2023 call → NOWe need to determine if management conveys that the reported results for Q4 2023 do not represent the business as it is actually running today, i.e., the reported period is stale relative to the operating present. Look for statements indicating that the business has already moved beyond what the numbers show, with concrete things already in motion. Key points: Kevin Sayer says 2023 was transformative, launched G7, expanded coverage, added 600k users, etc. But does he say the reported results are behind? He says "we are just getting started" but that's forward-looking. He notes that they are expanding salesforce, launching Stelo later this summer, etc. But those are future initiatives. However, he also says "we are already seeing more clinicians want to incorporate Dexcom CGM earlier" and "more than 70% of our new scripts are being written by primary care physicians." That is current. But does he say the Q4 numbers lag the current pace? Jereme discusses guidance for 2024, but not that Q4 is stale. Look for phrases like "the momentum continues to grow" or "we are ahead" but that's about guidance. Important: The question asks if management conveys that the reported results do not represent the business actually running today. That would be if they say something like "the quarter's results don't reflect the current run rate because we've since launched X" or "we've already moved beyond these numbers." In this call, they talk about strong results, record growth, but they don't explicitly say the period is stale. They do mention that G7 launched in 2023 and that's a big deal, but that's within the period. They say "we are just getting started" which is about future. They discuss that basal coverage went live in mid-April 2023, so that's in the period. They mention that they are expanding salesforce this year, but that's future. The key test: Does management repeatedly or substantially indicate that the just-reported numbers describe a company that has already been left behind? I don't see that. They are proud of the numbers. They do mention that G7 transition is ongoing and that they expect margins to improve as G7 scales, but that's about future. They also mention that they are investing in Stelo and salesforce, but that's for 2024. I think the answer is NO. The call is typical results and outlook. They don't say the reported period is behind. Thus answer NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| PFE | Pfizer Inc. | Q4 2023 | 2024-01-30 | F |
| SCPH | scPharmaceuticals Inc. | Q3 2023 | 2023-11-08 | B |
| NBTX | Nanobiotix S.A. | Q2 2023 | 2023-09-27 | D |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| VRE | Veris Residential, Inc. | Q4 2022 | 2023-02-22 | D |
| SOL | ReneSola Ltd | Q3 2022 | 2022-12-01 | C+ |
| FLL | Full House Resorts, Inc. | Q3 2022 | 2022-11-07 | B |
| OPK | OPKO Health, Inc. | Q1 2022 | 2022-05-09 | D |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
| LIND | Lindblad Expeditions Holdings, Inc. | Q2 2017 | 2017-08-06 | C |
VRE · Q4 2022 → YESThe question is: Does management convey that the reported results for the period do not represent the business the company is actually running today? That the just-reported numbers describe a company ...YES The transcript shows management repeatedly framing the reported period as transitional and not reflective of the current business: the shift to a pure-play multi-family company has already reduced office and hotel exposure while driving multi-family NOI share to 98%, with Haus25 leased at 95% ahead of schedule and same-store NOI guidance of 4-6% for 2023. They explicitly note that earnings variability stems from the ongoing asset sales and reallocation, with the business now positioned for growth as the transformation concludes, and they highlight post-period activity like additional sales and stabilized properties to underscore that the reported numbers capture a pre-transition state.
PFE · Q4 2023 → YESThe question is: Does management convey that the reported results do not represent the business the company is actually running today? That the just-reported numbers describe a company that has alread...NO The transcript shows management framing 2023 results as a challenging year with declines driven by COVID products, while positioning 2024 as a year of execution and growth through new priorities like the Seagen acquisition (closed late in 2023 with minimal contribution) and new product launches. This is a standard results-and 2024 outlook discussion, with forward-looking elements on pipeline, margins, and capital allocation rather than indicating the reported period is stale relative to current operations.
PRIM · Q2 2018 → YESThe question is whether management conveys that the reported results for Q2 2018 do not represent the business the company is actually running today. Specifically, if the printed period is stale relat...YES The transcript shows management repeatedly framing the Q2 results as a partial picture due to the late June 1 acquisition of Willbros. They note the business is "running as planned," highlight one-month revenue contribution of $1.